Cargando…
Pharmacoeconomics in Africa: needs, prospect and challenges
Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die from preventable and curable diseases. Population increases have led to an increase in dema...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166127/ https://www.ncbi.nlm.nih.gov/pubmed/34059103 http://dx.doi.org/10.1186/s40545-021-00328-5 |
_version_ | 1783701448731656192 |
---|---|
author | Ben-Ajepe, Temitope Nwogu, Ifechukwu Benedict Olaoye, Damilola Quazeem Mustapha, Abdulhafeez Ayodele Uwizeyimana, Theogene Adebisi, Yusuff Adebayo |
author_facet | Ben-Ajepe, Temitope Nwogu, Ifechukwu Benedict Olaoye, Damilola Quazeem Mustapha, Abdulhafeez Ayodele Uwizeyimana, Theogene Adebisi, Yusuff Adebayo |
author_sort | Ben-Ajepe, Temitope |
collection | PubMed |
description | Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die from preventable and curable diseases. Population increases have led to an increase in demands for healthcare, which unfortunately have been met with inequitable distribution of drugs. Hence, the outcomes from healthcare interventions are frequently not maximized. These problems notably call for some economic principles and policies to guide medication selection, procurement, or donation for population prioritization or health insurance. Pharmacoeconomics drives efficient use of scarce or limited resources to maximize healthcare benefits and reduce costs. It also brings to play tools that rate therapy choice based on the quality of life added to the patient after a choice of intervention was made over an alternative. In this paper, we commented on the needs, prospect, and challenges of pharmacoeconomics in Africa. |
format | Online Article Text |
id | pubmed-8166127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81661272021-06-02 Pharmacoeconomics in Africa: needs, prospect and challenges Ben-Ajepe, Temitope Nwogu, Ifechukwu Benedict Olaoye, Damilola Quazeem Mustapha, Abdulhafeez Ayodele Uwizeyimana, Theogene Adebisi, Yusuff Adebayo J Pharm Policy Pract Commentary Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die from preventable and curable diseases. Population increases have led to an increase in demands for healthcare, which unfortunately have been met with inequitable distribution of drugs. Hence, the outcomes from healthcare interventions are frequently not maximized. These problems notably call for some economic principles and policies to guide medication selection, procurement, or donation for population prioritization or health insurance. Pharmacoeconomics drives efficient use of scarce or limited resources to maximize healthcare benefits and reduce costs. It also brings to play tools that rate therapy choice based on the quality of life added to the patient after a choice of intervention was made over an alternative. In this paper, we commented on the needs, prospect, and challenges of pharmacoeconomics in Africa. BioMed Central 2021-05-31 /pmc/articles/PMC8166127/ /pubmed/34059103 http://dx.doi.org/10.1186/s40545-021-00328-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Ben-Ajepe, Temitope Nwogu, Ifechukwu Benedict Olaoye, Damilola Quazeem Mustapha, Abdulhafeez Ayodele Uwizeyimana, Theogene Adebisi, Yusuff Adebayo Pharmacoeconomics in Africa: needs, prospect and challenges |
title | Pharmacoeconomics in Africa: needs, prospect and challenges |
title_full | Pharmacoeconomics in Africa: needs, prospect and challenges |
title_fullStr | Pharmacoeconomics in Africa: needs, prospect and challenges |
title_full_unstemmed | Pharmacoeconomics in Africa: needs, prospect and challenges |
title_short | Pharmacoeconomics in Africa: needs, prospect and challenges |
title_sort | pharmacoeconomics in africa: needs, prospect and challenges |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166127/ https://www.ncbi.nlm.nih.gov/pubmed/34059103 http://dx.doi.org/10.1186/s40545-021-00328-5 |
work_keys_str_mv | AT benajepetemitope pharmacoeconomicsinafricaneedsprospectandchallenges AT nwoguifechukwubenedict pharmacoeconomicsinafricaneedsprospectandchallenges AT olaoyedamilolaquazeem pharmacoeconomicsinafricaneedsprospectandchallenges AT mustaphaabdulhafeezayodele pharmacoeconomicsinafricaneedsprospectandchallenges AT uwizeyimanatheogene pharmacoeconomicsinafricaneedsprospectandchallenges AT adebisiyusuffadebayo pharmacoeconomicsinafricaneedsprospectandchallenges |